Philip E.D. Chung

828 total citations
15 papers, 512 citations indexed

About

Philip E.D. Chung is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Philip E.D. Chung has authored 15 papers receiving a total of 512 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Philip E.D. Chung's work include Epigenetics and DNA Methylation (5 papers), Cancer-related Molecular Pathways (4 papers) and Glioma Diagnosis and Treatment (3 papers). Philip E.D. Chung is often cited by papers focused on Epigenetics and DNA Methylation (5 papers), Cancer-related Molecular Pathways (4 papers) and Glioma Diagnosis and Treatment (3 papers). Philip E.D. Chung collaborates with scholars based in Canada, United States and Italy. Philip E.D. Chung's co-authors include Eldad Zacksenhaus, Zhe Jiang, Jeff C. Liu, YoungJun Ju, Mariusz Shrestha, Sean E. Egan, Sonia B. Jakowlew, Terry W. Moody, Uri Nir and Robert A. Jones and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and The EMBO Journal.

In The Last Decade

Philip E.D. Chung

15 papers receiving 505 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Philip E.D. Chung Canada	11	350	201	200	59	51	15	512
S.Y. Cindy Yang Canada	15	520 1.5×	123 0.6×	181 0.9×	53 0.9×	54 1.1×	23	714
Kristina Althoff Germany	14	547 1.6×	197 1.0×	154 0.8×	47 0.8×	85 1.7×	21	727
Katarzyna B. Leszczyńska United Kingdom	15	476 1.4×	205 1.0×	212 1.1×	29 0.5×	49 1.0×	24	664
Michael D. Brewer United States	5	370 1.1×	130 0.6×	110 0.6×	25 0.4×	56 1.1×	5	478
Wanyin Chen China	10	277 0.8×	125 0.6×	204 1.0×	38 0.6×	71 1.4×	17	487
Kathryn N. Phoenix United States	11	538 1.5×	259 1.3×	236 1.2×	76 1.3×	70 1.4×	16	758
Qicong Luo China	13	464 1.3×	261 1.3×	158 0.8×	30 0.5×	54 1.1×	22	656
Iosifina P. Foskolou United Kingdom	14	388 1.1×	228 1.1×	202 1.0×	49 0.8×	135 2.6×	23	622
Boyko S. Atanassov United States	12	618 1.8×	90 0.4×	195 1.0×	71 1.2×	66 1.3×	20	729
Chenming Wu China	13	563 1.6×	101 0.5×	237 1.2×	49 0.8×	67 1.3×	22	658

Countries citing papers authored by Philip E.D. Chung

Since Specialization

Citations

This map shows the geographic impact of Philip E.D. Chung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip E.D. Chung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip E.D. Chung more than expected).

Fields of papers citing papers by Philip E.D. Chung

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip E.D. Chung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip E.D. Chung. The network helps show where Philip E.D. Chung may publish in the future.

Co-authorship network of co-authors of Philip E.D. Chung

This figure shows the co-authorship network connecting the top 25 collaborators of Philip E.D. Chung. A scholar is included among the top collaborators of Philip E.D. Chung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip E.D. Chung. Philip E.D. Chung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Jiang, Zhe, Philip E.D. Chung, Hang Tran, et al.. (2025). Recent Advances in Pineoblastoma Research: Molecular Classification, Modelling and Targetable Vulnerabilities. Cancers. 17(5). 720–720. 1 indexed citations

Ehli, Erik A., Christel M. Davis, Philip E.D. Chung, et al.. (2023). A temporal in vivo catalog of chromatin accessibility and expression profiles in pineoblastoma reveals a prevalent role for repressor elements. Genome Research. 33(2). 269–282. 2 indexed citations

Xiao, Xiao, Philip E.D. Chung, Mei Xu, et al.. (2022). A racemosin B derivative, C25, suppresses breast cancer growth via lysosomal membrane permeabilization and inhibition of autophagic flux. Biochemical Pharmacology. 201. 115060–115060. 2 indexed citations

Jiang, Zhe, Huiqin Li, Stephanie A. Schroer, et al.. (2022). Hypophosphorylated pRb knock‐in mice exhibit hallmarks of aging and vitamin C‐preventable diabetes. The EMBO Journal. 41(4). e106825–e106825. 14 indexed citations

Chung, Philip E.D. & Eldad Zacksenhaus. (2020). Methylation data of mouse Rb-deficient pineoblastoma. SHILAP Revista de lepidopterología. 32. 106229–106229. 1 indexed citations

Xiao, Xiao, Mei Xu, Yao Yao, et al.. (2018). Novel racemosin B derivatives as new therapeutic agents for aggressive breast cancer. Bioorganic & Medicinal Chemistry. 26(23-24). 6096–6104. 16 indexed citations

Zacksenhaus, Eldad, Jeff C. Liu, Letizia Granieri, et al.. (2018). CDC25 as a common therapeutic target for triple-negative breast cancer - the challenges ahead. Molecular & Cellular Oncology. 5(4). e1481814–e1481814. 11 indexed citations

Zacksenhaus, Eldad, Mariusz Shrestha, Jeff C. Liu, et al.. (2017). Mitochondrial OXPHOS Induced by RB1 Deficiency in Breast Cancer: Implications for Anabolic Metabolism, Stemness, and Metastasis. Trends in cancer. 3(11). 768–779. 105 indexed citations

Jones, Robert A., Tyler Robinson, Jeff C. Liu, et al.. (2016). RB1 deficiency in triple-negative breast cancer induces mitochondrial protein translation. Journal of Clinical Investigation. 126(10). 3739–3757. 99 indexed citations

10.

Deng, Tao, Jeff C. Liu, Philip E.D. Chung, et al.. (2014). shRNA Kinome Screen Identifies TBK1 as a Therapeutic Target for HER2+ Breast Cancer. Cancer Research. 74(7). 2119–2130. 29 indexed citations

11.

Jiang, Zhe, Jeff C. Liu, Philip E.D. Chung, Sean E. Egan, & Eldad Zacksenhaus. (2014). Targeting HER2+ breast cancer: the TBK1/IKK-Epsilon axis. Oncoscience. 1(2). 180–182. 20 indexed citations

12.

Hong, Jenny H., Anne C. Ferguson‐Smith, Carol Moreno, et al.. (2011). Recent acquisition of imprinting at the rodent Sfmbt2 locus correlates with insertion of a large block of miRNAs. BMC Genomics. 12(1). 204–204. 46 indexed citations

13.

Jiang, Zhe, Robert A. Jones, Jeff C. Liu, et al.. (2011). RB1 and p53 at the crossroad of EMT and triple-negative breast cancer. Cell Cycle. 10(10). 1563–1570. 82 indexed citations

14.

Draoui, Muriel, et al.. (1995). Bombesin stimulates c-fos and c-jun mRNAs in small cell lung cancer cells. Peptides. 16(2). 289–292. 38 indexed citations

15.

Jakowlew, Sonia B., Askale Mathias, Philip E.D. Chung, & Terry W. Moody. (1995). Expression of transforming growth factor beta ligand and receptor messenger RNAs in lung cancer cell lines.. PubMed. 6(4). 465–76. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact